EGPAF Guidance and Algorithm for Follow-Up of Children After Starting or Transitioning to pDTG
The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to,...
top of page
A framework to support new product introduction in national health systems
Resource Library
May 24, 2022
GAP-f pDTG Implementation Considerations for National Programmes
In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...
366
Feb 9, 2022
WHO Pediatric ARV Dosing Dashboard
The WHO Pediatric ARV dosing dashboard aims to support health care workers, researchers and policy makers in decisions around ARV dosing...
705
Jul 31, 2021
2021 WHO Guidelines
A compilation of recently published WHO guidelines, including CHAI briefs on these guidelines. 2021 WHO Consolidated Guidelines on HIV...
99
Jul 19, 2021
Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...
25
Jul 16, 2021
WHO Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring
These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new...
40
Jun 30, 2021
How-To Guide: Implementing Weight-Based ART Monitoring
A how-to guide for implementing weight-based ART monitoring for improving pediatric treatment optimization outcomes. This guide, in...
6
May 14, 2021
CHAI Briefs on Updated WHO Guidelines
In March 2021, the WHO published new clinical and service delivery recommendations for HIV prevention, treatment, and care. In April, the...
12
Apr 25, 2021
2021 WHO Optimal Formulary and Limited-Use List for ARVs for Children
This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for...
6
Jul 1, 2020
WHO Package of care for children and adolescents with advanced HIV disease
WHO published guidelines on the management of advanced HIV disease in 2017, promoting a package of interventions to prevent, identify and...
13
May 28, 2020
Optimizing 2L HIV Treatment with DTG-based Regimens
This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...
17
Aug 1, 2018
TLD Resources
CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
73
Jul 14, 2017
WHO Guidelines on the public health response to pretreatment HIV drug resistance
This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside...
11
bottom of page